Compare KPTI & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KPTI | TPCS |
|---|---|---|
| Founded | 2008 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.6M | 45.1M |
| IPO Year | 2013 | 2008 |
| Metric | KPTI | TPCS |
|---|---|---|
| Price | $1.96 | $5.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 53.7K |
| Earning Date | 05-04-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.38 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $146,067,000.00 | $31,644,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.36 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $1.79 | $2.88 |
| 52 Week High | $10.99 | $6.31 |
| Indicator | KPTI | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 22.86 | 66.43 |
| Support Level | N/A | $4.41 |
| Resistance Level | $2.18 | N/A |
| Average True Range (ATR) | 0.17 | 0.28 |
| MACD | 0.15 | 0.09 |
| Stochastic Oscillator | 34.62 | 69.10 |
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.